Craig Anderson's Publications

About Craig Anderson's Publications

Director, Brain Health Program, The George Institute
  • Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney

  • Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

    Stroke and Vascular Neurology Date published:

  • The report from roundtable discussion on women’s health through life course and empowerment.

    Date published:

  • OPTIMAL ANALYSIS OF THE MODIFIED RANKIN SCALE (MRS)

    Date published:

  • Comparison between right and left acute ischaemic stroke patients treated with intravenous alteplase in the ENCHANTED trial

    Date published:

  • To treat acute ischemic stroke with standard-dose or low-dose alteplase? An individualized decision making tool

    Date published:

  • SEX DIFFERENCE IN SPECIFIC-CAUSE OF EXCESS DEATH RATES AFTER STROKE: THE AUSTRALIAN STROKE CLINICAL REGISTRY (AuSCR)

    Date published:

  • DIFFERENCES IN STROKE CARE AND OUTCOMES AFTER STROKE FOR WOMEN COMPARED TO MEN: AUSTRALIAN STROKE CLINICAL REGISTRY

    Date published:

  • AN INDIVIDUALISED DECISION MAKING TOOL FOR USE OF LOW VERSUS STANDARD DOSE ALTEPLASE IN ACUTE ISCHAEMIC STROKE

    Date published:

  • Stroke Incidence by Major Pathological Type and Ischemic Subtypes in the Auckland Regional Community Stroke Studies

    Stroke Date published:

  • Discrepant relationships between admission blood pressure and mortality in different stroke subtypes

    Journal of the Neurological Sciences Date published:

  • Effects of cpap therapy on blood pressure variability (BPV) in people with comorbid obstructive sleep apnoea (OSA) and cardiovascular disease (CVD): save trial

    Sleep Medicine Date published:

  • Effect of Obstructive Sleep Apnea Treatment on Renal Function in Patients with Cardiovascular Disease

    American Journal of Respiratory and Critical Care Medicine Date published:

  • Frequency, Aetiology, and Outcome of Small Cerebellar Infarction

    Cerebrovascular Diseases Extra Date published:

  • Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke

    JAMA Neurology Date published:

  • Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time

    Scientific Reports Date published:

  • Early Cognitive Impairment after Intracerebral Hemorrhage in the INTERACT1 Study

    Cerebrovascular Diseases Date published: